Adam M. Swartz

609 total citations
18 papers, 364 citations indexed

About

Adam M. Swartz is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Adam M. Swartz has authored 18 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Adam M. Swartz's work include Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (8 papers) and RNA Interference and Gene Delivery (6 papers). Adam M. Swartz is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (8 papers) and RNA Interference and Gene Delivery (6 papers). Adam M. Swartz collaborates with scholars based in United States. Adam M. Swartz's co-authors include John H. Sampson, Qi-Jing Li, Kristen A. Batich, Peter E. Fecci, Smita K. Nair, Luis Sánchez-Pérez, Carter M. Suryadevara, James E. Herndon, Patrick Healy and Elizabeth A. Reap and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and The Journal of Immunology.

In The Last Decade

Adam M. Swartz

18 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam M. Swartz United States 10 206 196 126 120 45 18 364
Alba Matas‐Céspedes Spain 10 168 0.8× 186 0.9× 103 0.8× 100 0.8× 20 0.4× 19 370
Andrea Pepper United Kingdom 8 132 0.6× 187 1.0× 121 1.0× 77 0.6× 36 0.8× 19 348
Weihong Chen China 5 152 0.7× 186 0.9× 117 0.9× 136 1.1× 14 0.3× 8 396
Jaime Richardson United States 4 205 1.0× 216 1.1× 64 0.5× 171 1.4× 18 0.4× 8 316
Catherine Flores United States 9 243 1.2× 235 1.2× 148 1.2× 189 1.6× 50 1.1× 15 426
Aditya Mohan United States 11 201 1.0× 212 1.1× 137 1.1× 56 0.5× 28 0.6× 26 414
Shruthi Prasad Germany 5 130 0.6× 242 1.2× 80 0.6× 45 0.4× 63 1.4× 7 337
Marion Alcantara France 9 121 0.6× 259 1.3× 103 0.8× 74 0.6× 49 1.1× 24 402
Petra Vočková Czechia 10 58 0.3× 196 1.0× 179 1.4× 89 0.7× 47 1.0× 18 385
Mia Mazer United States 4 405 2.0× 398 2.0× 115 0.9× 294 2.5× 28 0.6× 10 552

Countries citing papers authored by Adam M. Swartz

Since Specialization
Citations

This map shows the geographic impact of Adam M. Swartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam M. Swartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam M. Swartz more than expected).

Fields of papers citing papers by Adam M. Swartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam M. Swartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam M. Swartz. The network helps show where Adam M. Swartz may publish in the future.

Co-authorship network of co-authors of Adam M. Swartz

This figure shows the co-authorship network connecting the top 25 collaborators of Adam M. Swartz. A scholar is included among the top collaborators of Adam M. Swartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam M. Swartz. Adam M. Swartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Swartz, Adam M., Michael C. Brown, Alejandro Barrera, et al.. (2023). Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens. Nature Genetics. 55(12). 2211–2223. 37 indexed citations
2.
Parker, Scott, Luis Sánchez-Pérez, Cristina Osorio, et al.. (2023). Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models. Science Translational Medicine. 15(682). eabn5649–eabn5649. 16 indexed citations
3.
Swartz, Adam M., et al.. (2022). Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models. Cancers. 14(19). 4669–4669. 3 indexed citations
4.
Swartz, Adam M. & Smita K. Nair. (2022). The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells. Current Protocols. 2(4). e410–e410. 6 indexed citations
5.
Swartz, Adam M., Kendra L. Congdon, Smita K. Nair, et al.. (2021). A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope. npj Vaccines. 6(1). 12–12. 11 indexed citations
6.
Swartz, Adam M., Kelly Hotchkiss, Smita K. Nair, John H. Sampson, & Kristen A. Batich. (2021). Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype. Methods in molecular biology. 2410. 609–626. 2 indexed citations
7.
Swartz, Adam M., Katherine A. Riccione, Kendra L. Congdon, et al.. (2020). Synthetic long peptide vaccines possessing a universal helper epitope can unmask the therapeutic effects of MHC I-restricted neoepitopes. The Journal of Immunology. 204(1_Supplement). 91.26–91.26. 1 indexed citations
8.
Huang, Min-Nung, Kristen A. Batich, Adam M. Swartz, et al.. (2019). Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses. Journal of Clinical Investigation. 130(2). 774–788. 48 indexed citations
9.
Riccione, Katherine A., Li-Zhen He, Peter E. Fecci, et al.. (2018). CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response. OncoImmunology. 7(12). e1502904–e1502904. 10 indexed citations
10.
Swartz, Adam M., et al.. (2018). Promising vaccines for treating glioblastoma. Expert Opinion on Biological Therapy. 18(11). 1159–1170. 12 indexed citations
11.
Swartz, Adam M., Elizabeth A. Reap, Pamela K. Norberg, et al.. (2018). A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis. Journal of Immunological Methods. 459. 90–93. 5 indexed citations
12.
Suryadevara, Carter M., Rupen Desai, S. Harrison Farber, et al.. (2018). Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts. Clinical Cancer Research. 25(1). 358–368. 55 indexed citations
13.
Batich, Kristen A., Adam M. Swartz, & John H. Sampson. (2016). Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy. Methods in molecular biology. 1403. 819–838. 7 indexed citations
14.
Suryadevara, Carter M., Rupen Desai, S. Harrison Farber, et al.. (2016). 369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts. Neurosurgery. 63(Supplement 1). 209–210. 3 indexed citations
15.
Batich, Kristen A., Adam M. Swartz, & John H. Sampson. (2014). Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma. Expert Opinion on Biological Therapy. 15(1). 79–94. 16 indexed citations
16.
Swartz, Adam M., Kristen A. Batich, Peter E. Fecci, & John H. Sampson. (2014). Peptide vaccines for the treatment of glioblastoma. Journal of Neuro-Oncology. 123(3). 433–440. 48 indexed citations
17.
Swartz, Adam M., Qi-Jing Li, & John H. Sampson. (2014). Rindopepimut: A Promising Immunotherapeutic for the Treatment of Glioblastoma Multiforme. Immunotherapy. 6(6). 679–690. 78 indexed citations
18.
Swartz, Adam M., et al.. (2013). The Right Tool for the Right Job. Journal of Ambulatory Care Management. 36(3). 241–244. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alba Matas‐Céspedes Breakdown of academic impact, for papers by Andrea Pepper Breakdown of academic impact, for papers by Weihong Chen Breakdown of academic impact, for papers by Jaime Richardson Breakdown of academic impact, for papers by Catherine Flores Breakdown of academic impact, for papers by Aditya Mohan Breakdown of academic impact, for papers by Shruthi Prasad Breakdown of academic impact, for papers by Marion Alcantara Breakdown of academic impact, for papers by Petra Vočková Breakdown of academic impact, for papers by Mia Mazer
Rankless by CCL
2026